← Eichor
Study identifier: NCT07033169 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis

Condition: Dermatologic Disease  ·  Sponsor: Wake Forest University Health Sciences

PhaseN/A
Planned participants400
Who can joinAll sexes, 10 Years to no upper limit
Healthy volunteersNo

About this study

Consented patients will have three images taken of their dermatologic conditions within the Belle.ai software. These images will be uploaded and saved within the Belle software system where a single AI-generated differential list will be generated based on the three photos. All photos uploaded will be de-identified. The software will not have any unique identifiers of participants saved in the system. The photos will be named based on participant enrollment numbers or unique code numbers and no unique identifiers will be attached to the photos. There will be no data collection form necessary for this study

This description comes directly from the study's public registry record.

Talk to the study team

Irma M Richardson, MHA  ·  336-716-2903  ·  irichard@wakehealth.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Wake Forest University Health Sciences Department of DermatologyWinston-Salem, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07033169